SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Director/PDMR Shareholding

9 Mar 2021 15:30

RNS Number : 6874R
Rotork PLC
09 March 2021
 

 

9 March 2021

 

Rotork plc

 ("Company")

 

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

 

The Company provides notification of the following transactions, all effected on 8 March 2021 outside of a market venue, relating to the two below named Executive Directors as PDMRs and their respective interests in the ordinary share capital of the Company ("Shares") (ISIN: GB00BVFNZH21).

 

The transactions arise from: (i) the conditional award of Shares granted to Kevin Hostetler and Jonathan Davis under the Company's Deferred Annual Bonus Plan 2018 ("DABP") relating to the three-year deferred element of their respective 2020 annual bonus, and (ii) the exercise and immediate dealing by Jonathan Davis of a fully vested nil cost option award over certain Shares granted to him on 7 March 2018 under the Company's DABP relating to the three-year deferred element of his 2017 annual bonus.

 

Individual PDMR details are set out in the table below:

 

Name and position of PDMR

No. of conditional award Shares granted on 8 March 2021 as per (i) above ¹ ²

 

No. of Shares acquired on exercise, sold and retained on 8 March 2021 as per (ii) above

Kevin Hostetler,

Chief Executive

 

18,533

N/A

Jonathan Davis,

Group Finance Director

 

8,544

15,438 Shares acquired ³ (including dividend equivalent) 7,231 Shares sold at 365.20p per share

8,207 Shares retained

 

 

¹ Recovery and Withholding apply to the conditional award Shares granted under the DABP for three-years from the date of grant, including post cessation of employment. A dividend equivalent entitlement also attaches to the Shares.

² The amount of the 2020 annual bonus being deferred for Messrs. Hostetler and Davis is £67,685 (12.9%) and £31,203 (12.9%) respectively. The number of conditional award Shares were determined based on a share price of 365.20p, being the MMQ of a Rotork share on the business day immediately preceding the date of grant, ie on 5 March 2021 ("Strike Price").

³ The Shares acquired on exercise were existing market purchased Shares delivered from the Company's Employee Benefit Trust ("EBT").

The Shares sold were to cover Jonathan Davis' immediate personal income tax and social security liability arising on exercise. The Shares sold were purchased by the EBT at the Strike Price.

The Shares retained are held in the name of Jonathan Davis' spouse, a Person Closely Associated with him as defined under the EU Market Abuse Regulation ("MAR").

 

Full details relating to: (a) the 2020 annual bonus outturns for the Executive Directors and the corresponding 2021 DABP conditional Shares award to them, and (b) the 2018 DABP Shares vesting to Jonathan Davis, will appear in the Directors' Remuneration Report to the Company's 2020 Annual Report due to be published on 30 March 2021.

 

The Company can confirm that each of the above named PDMRs have complied with their respective obligation to notify the Financial Conduct Authority of the above transactions as required under MAR.

 

- END -

 

Rotork contact and telephone number for enquiries:

Sandra Forbes, Group General Counsel & Company Secretary (Interim)

++44 (0) 7775 703 579

 

Notes:

Legal Entity Identifier: 213800AH5RZIHGWRJ718

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBSGDXSSGDGBC
Date   Source Headline
11th Jun 202612:08 pmRNSDirector/PDMR Shareholding
1st Jun 20269:34 amRNSTotal Voting Rights
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20265:57 pmRNSDirector/PDMR Shareholding
12th May 202612:25 pmRNSDirector/PDMR Shareholding
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 202610:45 amRNSResult of AGM
1st May 20269:53 amRNSTotal Voting Rights
1st May 20267:00 amRNSTrading update
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 202610:49 amRNSDirector/PDMR Shareholding
21st Apr 20264:58 pmRNSHolding(s) in Company
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20263:18 pmRNSDirector/PDMR Shareholding
15th Apr 20261:19 pmRNSShare buyback programme
13th Apr 20264:37 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20268:52 amRNSDirector/PDMR Shareholding
7th Apr 20269:52 amRNSTransaction in Own Shares - Clarification Notice
7th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20269:10 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20263:03 pmRNS2025 Annual Report and Notice of 2026 AGM
26th Mar 20261:55 pmRNSDirector/PDMR Shareholding
25th Mar 202611:36 amRNSDirector/PDMR Shareholding
23rd Mar 20262:38 pmRNSHolding(s) in Company
23rd Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 202611:01 amRNSDirector/PDMR Shareholding
13th Mar 20261:54 pmRNSShare buyback programme
11th Mar 20264:00 pmRNSHolding(s) in Company
11th Mar 20264:00 pmRNSHolding(s) in Company
11th Mar 202612:16 pmRNSDirector/PDMR Shareholding
11th Mar 202612:16 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS2025 full year results
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20261:16 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.